Jonathan Wolff, Alfred Landecker Professor of Values and Public Policy, is among the authors of 'What are the obligations of pharmaceutical companies in a global health emergency?' published in The Lancet.
The article explores the moral obligations of pharmaceutical companies during a pandemic. All parties involved in researching, developing, manufacturing, and distributing COVID-19 vaccines need guidance on their ethical obligations. The authors focus on pharmaceutical companies' obligations because their capacities to research, develop, manufacture, and distribute vaccines make them uniquely placed for stemming the pandemic.
The authors state "an ethical approach to COVID-19 vaccine production and distribution should satisfy four uncontroversial principles: optimising vaccine production, including development, testing, and manufacturing; fair distribution; sustainability; and accountability."
Recent research updates
New paper by Thomas Elston the impact of timing on the success of public sector collaborations
Published in Public Management Review, the article uses inter-municipal partnerships in Catalonia between 2009–19 as a case study to test whether the timing of inter-municipal cooperation, and its duration, affect financial performance.